Skip to content
News
We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.
April 17, 2023
Sapphiros Awarded $11M from NIH RADx® Tech to Develop a Next-generation Molecular OTC Test
READ MORE
January 25, 2023
Sapphiros Taps Teresa Abraham for VP of Scientific and Technical Affairs
READ MORE
January 20, 2023
Biocrucible, a Sapphiros Company, Appoints Per Grufman as CEO
READ MORE
October 27, 2022
Sapphiros Appoints Mark Gladwell as CEO and President
READ MORE
September 8, 2022
Sapphiros Acquires Flexotronix Limited
READ MORE
September 6, 2022
Mike Musgnug Joins Sapphiros as Executive Vice President, Strategy and CEO, GrapheneDx
READ MORE
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us